Arkema to buy U.S.-based ArrMaz in deal worth $570 millionChristian Fernsby ▼ |
Acquisition ArrMaz is a global leader in specialty surfactants for crop nutrition
Arkema will buy U.S. company ArrMaz in a deal worth $570 million on an enterprise-value basis.
The price of the company’s takeover of ArrMAZ was based on an enterprise value of $570 million, which corresponds to an EV/EBITDA multiple of 10.8 times, Arkema said.
The takeover is expected to have an accretive impact on cash and earnings per share from the first year of integration, the French chemical manufacturer added. ■
What to read next